Colombian President Gustavo Petro is embroiled in controversy following the tragic death of Kevin Acosta, a seven-year-old boy suffering from hemophilia. Acosta's death is attributed to a lack of the medication Emicizumab, which he was unable to receive for two months. This situation escalated when President Petro publicly shared Acosta's medical history and suggested that the child’s family was partly responsible due to allowing him to engage in sports activities, such as riding a bicycle, despite his serious condition.

In a public event, Petro spoke about the child's symptoms leading to his death, mentioning episodes of unconsciousness alongside bleeding from both the ears and nose. His comments that the mother was negligent for allowing her son to participate in sports, despite the risks associated with hemophilia, have been met with significant public outcry. Critics argue that the focus should be on systemic healthcare failures rather than blaming the grieving family.

This incident highlights ongoing issues within Colombia's healthcare system, particularly concerning the availability and accessibility of critical medications for chronic conditions like hemophilia. The community and health advocates are calling for a reevaluation of healthcare policies to ensure such tragedies do not recur, emphasizing that public health officials should not shift blame onto families dealing with life-threatening conditions when healthcare access is compromised.